ZYMERON CORPORATION
Non-invasive aerosol therapy for acute respiratory distress syndrome (ARDS) management
- Sector
- Medtech
- Headquarters
- Durham, NC
- Total capital
- $12.7M
- Federal grants
- $12.7M
- 22 awards · 2017–2024
- Rank in peer group#27 of 538
- Private capital raised
- None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 2
- 8 pending · first 2025
- Rank in peer group#190 of 538
Capital timeline
Latest events
- Federal grantDefense · Phase II · Dha SBIR Direct Phase II H2D-0243 Rapid Sample Processing Device To Support Battlefield Wound Infection Diagnostics$3M
- Federal grantDefense · Phase I · Dha STTR Phase 1 Medical Research And Development Purchase Order For "proposal H23C-002-0028 "development Of Woundshield For Pseudomonas Aeruginosa-caused Wounds Infections"$250K
- Federal grantDefense · Phase I · Research And Development$197K
- Federal grantEnergy · Phase I · Advanced portable low temperature plasma device for chronic wound disinfection and healing$200K
- Federal grantDefense · Phase I · Novel Aerosol Therapy for Immediate and Sustained ARDS Management$250K
- Federal grantDefense · Phase I · Small Molecule Therapeutics Targeting Members of the Bunyavirales Order$167K
- Federal grantDefense · Phase II · Development for a novel countermeasure, RadioDefender, as a radioprotector for hematopoietic acute radiation syndrome$3M
Show 8 earlier federal awards
- Federal grantDefense · Phase I · Large Area Opioid Identification by Bioengineered Broad-Spectrum Receptors$167K
- Federal grantDefense · Phase I · Prophylactics for Ionizing Radiation-induced Hematopoietic Subsyndrome of ARS$250K
- Federal grantDefense · Phase I · Immediate Decontamination Kit for Military Working Dogs in Fields$167K
- Federal grantDefense · Phase I · Rapid Point of Care Diagnostic Tests to Determine Dengue Serostatus$111K
- Federal grantDefense · Phase I · One-Step Production of Water Barrier Filter for Super Clean and Dry Jet Fuel$108K
- Federal grantDefense · Phase I · Long Lasting Drug Implants for Malaria Chemoprophylaxis$150K
- Federal grantDefense · Phase II · Dermal Medical Countermeasures for Chemical Weapons Exposure$983K
- Federal grantDefense · Phase I · Dermal Medical Countermeasures for Chemical Weapons Exposure$150K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
7 records have no date or no amount, so they aren’t placed on the timeline.
Standing among 538 peers
Line = medianMedtech · Device
- Federal grants#27 · top 5%
- Granted patents#190 · top 35%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
No founders are linked to this company yet.
Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.
Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026
Claim this profile to add your teamWhat it has protected
USPTO · 2 granted of 10- PendingInjectable Formulations Of Parp Inhibitors And Uses ThereofUSPTOApplication 19271603
- GrantedInjectable Formulations Of Parp Inhibitors And Uses ThereofUSPTOUS 12,383,633
- PendingDrug Conjugates For Bone Marrow ProtectionUSPTOApplication 18777277
Show all 10 patent records
- Injectable Formulations Of Parp Inhibitors And Uses ThereofApr 2, 2026 · Application 19271603Pending
- Injectable Formulations Of Parp Inhibitors And Uses ThereofAug 12, 2025 · US 12,383,633Granted
- Drug Conjugates For Bone Marrow ProtectionApr 24, 2025 · Application 18777277Pending
- Novel Immunoassay Platform for the Serological Discrimination of Closely Related VirusesJan 14, 2025 · US 12,196,755Granted
- Plasmonic Nanoparticle Platform For Analyte DetectionAug 29, 2024 · Application 18538408Pending
- Plasmonic Nanoparticle Platform For Analyte DetectionApplication PCTUS2023083790Pending
- Drug Conjugates For Bone Marrow ProtectionApplication 63514530Pending
- Plasmonic Nanoparticle Platform For Analyte DetectionApplication 63484683Pending
- A Novel Immunoassay Platform For The Serological Discrimination Of Closely Related VirusesApplication PCTUS2022080801Pending
- Drug Conjugates For Bone Marrow ProtectionApplication PCTUS2024038573Pending
Related companies, and why
- GENNEXT TECHNOLOGIES, INC.Similar federal contract value in Medtech · null in contracts
- ALERJE, INC.Similar federal contract value in Medtech · null in contracts
- Vigilant Diagnostics LLCSimilar federal contract value in Medtech · null in contracts
- Farapulse, Inc.Similar federal contract value in Medtech · null in contracts
- SphereVis LLCSimilar federal contract value in Medtech · null in contracts
- XCMR INCSimilar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .